Nov 12 (Reuters) - Arix Bioscience PLC ARIX.L :
* ARIX BIOSCIENCE PLC - INVESTED $8.0 MILLION IN $70 MILLION
SERIES C FINANCING OF HARPOON THERAPEUTICS INC
* ARIX BIOSCIENCE PLC - RETAINS AN 11.3% STAKE ON A FULLY
DILUTED
BASIS AND ARIX'S MARK CHIN WILL CONTINUE TO SERVE ON HARPOON'S
BOARD
* ARIX BIOSCIENCE PLC - HARPOON EXPECTS TO ADVANCE ITS FIRST
PROTRITAC PRODUCT CANDIDATE INTO IND-ENABLING STUDIES IN 2019
Source text for Eikon: ID:nPRrCB424a
Further company coverage: ARIX.L
((Reuters.Briefs@thomsonreuters.com;))